Trinity Biotech plc (TRIB) DCF Valuation

Valoración de DCF de Trinity Biotech PLC (TRIB)

IE | Healthcare | Medical - Diagnostics & Research | NASDAQ
Trinity Biotech plc (TRIB) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Trinity Biotech plc (TRIB) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Diseñada para la precisión, nuestra calculadora DCF (TRIB) le permite evaluar la valoración de Trinity Biotech PLC utilizando datos financieros reales y proporciona flexibilidad completa para modificar todos los parámetros clave para mejorar las proyecciones.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 90.4 102.0 93.0 74.8 56.8 51.2 46.1 41.6 37.4 33.7
Revenue Growth, % 0 12.77 -8.84 -19.56 -24 -9.91 -9.91 -9.91 -9.91 -9.91
EBITDA -19.5 21.5 10.6 -16.7 -24.1 -5.5 -5.0 -4.5 -4.0 -3.6
EBITDA, % -21.59 21.11 11.39 -22.35 -42.4 -10.77 -10.77 -10.77 -10.77 -10.77
Depreciation 4.9 3.1 2.7 2.3 1.8 1.8 1.6 1.5 1.3 1.2
Depreciation, % 5.41 3.02 2.95 3.12 3.13 3.53 3.53 3.53 3.53 3.53
EBIT -24.4 18.4 7.8 -19.0 -25.9 -7.3 -6.6 -5.9 -5.4 -4.8
EBIT, % -27 18.09 8.44 -25.47 -45.53 -14.29 -14.29 -14.29 -14.29 -14.29
Total Cash 16.4 27.3 25.9 6.6 3.7 9.0 8.1 7.3 6.6 5.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 22.4 24.6 15.7 13.4 13.4
Account Receivables, % 24.76 24.12 16.9 17.98 23.54
Inventories 32.0 30.2 29.1 22.5 19.9 16.5 14.9 13.4 12.1 10.9
Inventories, % 35.41 29.63 31.33 30.09 35.07 32.31 32.31 32.31 32.31 32.31
Accounts Payable 7.8 7.1 6.8 6.2 3.9 3.9 3.5 3.2 2.8 2.6
Accounts Payable, % 8.66 6.97 7.27 8.3 6.84 7.61 7.61 7.61 7.61 7.61
Capital Expenditure -15.4 -10.2 -8.7 -6.0 -.8 -4.7 -4.2 -3.8 -3.4 -3.1
Capital Expenditure, % -16.98 -10 -9.35 -7.99 -1.41 -9.15 -9.15 -9.15 -9.15 -9.15
Tax Rate, % 34.96 34.96 34.96 34.96 34.96 34.96 34.96 34.96 34.96 34.96
EBITAT 120.9 16.7 9.1 -19.0 -16.8 -5.2 -4.7 -4.2 -3.8 -3.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 63.9 8.5 12.8 -14.3 -15.5 -2.3 -4.9 -4.4 -4.0 -3.6
WACC, % 0.81755 13.32 14.61 14.55 9.79 10.62 10.62 10.62 10.62 10.62
PV UFCF
SUM PV UFCF -14.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -4
Terminal Value -43
Present Terminal Value -26
Enterprise Value -40
Net Debt 64
Equity Value -104
Diluted Shares Outstanding, MM 8
Equity Value Per Share -13.55

What You Will Receive

  • Authentic Trinity Biotech Data: Comprehensive financials – from revenue to EBIT – based on real and forecasted figures.
  • Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Immediate Valuation Updates: Automatic recalculations to assess the effects of changes on Trinity Biotech’s fair value.
  • Flexible Excel Template: Designed for quick modifications, scenario analysis, and in-depth projections.
  • Efficient and Precise: Avoid starting models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Customizable Forecast Inputs: Adjust essential factors such as revenue projections, gross margins, and R&D expenses.
  • Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and additional financial metrics.
  • High-Precision Accuracy: Leverages Trinity Biotech's actual financial data for credible valuation results.
  • Effortless Scenario Analysis: Evaluate various assumptions and analyze results with ease.
  • Efficiency Booster: Avoid the complexity of constructing detailed valuation models from the ground up.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Trinity Biotech plc’s pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
  5. Step 5: Analyze the outputs and leverage the results for informed investment decisions regarding Trinity Biotech plc (TRIB).

Why Choose This Calculator?

  • User-Friendly Interface: Tailored for both novices and seasoned professionals.
  • Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
  • Real-Time Feedback: Observe immediate updates to Trinity Biotech's valuation as you modify inputs.
  • Preloaded Data: Comes equipped with Trinity Biotech's actual financial information for swift evaluations.
  • Relied Upon by Experts: Trusted by investors and analysts for making well-informed choices.

Who Should Use Trinity Biotech plc (TRIB)?

  • Investors: Gain insights and make informed decisions with our advanced biotechnology analysis tools.
  • Financial Analysts: Streamline your workflow with customizable financial models tailored to the biotech sector.
  • Consultants: Easily modify our resources for effective client presentations and strategic reports.
  • Biotech Enthusiasts: Enhance your knowledge of the industry through comprehensive case studies and real-world applications.
  • Educators and Students: Utilize our materials as a hands-on resource in biotechnology and finance courses.

What the Template Contains

  • Preloaded TRIB Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.